Managbanag, Roberto .

HRN: 29-06-26  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/27/2026
06/03/2026
IV
4.5g
Q8
Urosepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines